Interview Questions and Answers Related to Clinical Research

These are the often-asked questions in interviews for jobs involving clinical research. After reading this, you can see that practically all queries are connected to the fundamentals of clinical research.

What is clinical research?

Clinical research is a branch of healthcare science that aims to determine the safety and effectiveness of medications, devices, diagnostic products, and treatment regimens intended for human use. It involves conducting studies that may be used for the prevention, treatment, diagnosis, or symptom relief of disease. Clinical trials are often performed to assess whether a potential treatment is more effective or has fewer side effects than the current therapy.

What are the phases of clinical trials?

Clinical trials are typically divided into several phases, each with its own objectives and participant requirements:

1. Pre-clinical phase: This phase involves conducting tests on animals and in vitro to evaluate the potential risks and effects of a drug or therapeutic technique before human administration.
2. Phase 1: Also known as the dosing phase, this phase focuses on determining the optimal administration method (e.g., oral, injection) and dosage frequency of the medication. It primarily involves assessing the drug's safety and pharmacokinetics/pharmacodynamics and usually includes healthy individuals as participants.
3. Phase 2: In this phase, the trial continues to evaluate the safety and tolerability of the treatment. It also assesses the drug's effectiveness in a larger group of volunteers.
4. Phase 3: These studies compare the experimental therapy to the standard treatment for a particular condition, evaluating its effectiveness and side effects. Participants are randomly assigned to receive either the experimental treatment or the existing standard.
5. Phase 4: This phase occurs after the treatment has been approved and marketed. It aims to gather additional information about the treatment's risks, benefits, and best practices. Phase 4 trials can involve thousands of participants.

What is randomization in clinical trials?

Randomization in clinical trials refers to the process of assigning patients randomly to either the experimental or control group. This means that participants are given the experimental medication, a placebo, or standard care in a random manner. Randomization helps ensure that the groups are balanced and reduces bias in the study.

What is informed consent before a clinical trial starts?

• Informed consent is the process where potential participants in a clinical trial are provided with detailed information about the study, including its objectives, potential outcomes, sponsors, and possible risks. After receiving this information, participants are given the opportunity to ask questions and fully understand the study. 
• If they agree to participate, they are asked to sign an informed consent statement. Unlike a contract, participation in a clinical trial is voluntary, and participants can withdraw at any time without penalties or loss of benefits. The research team is responsible for maintaining ongoing informed consent throughout the study by providing any new or evolving information to the participants as needed.

What is a protocol in clinical research?

A protocol in clinical research is a detailed research plan or strategy that guides the clinical trial. It is carefully designed to protect the participants' health while addressing specific research objectives. The protocol outlines criteria for patient inclusion, the schedule of testing procedures, drug dosages, and the duration of the study.

What are the roles and responsibilities of a Clinical Research Associate (CRA)?

A Clinical Research Associate (CRA) is responsible for overseeing and monitoring clinical studies. They can work for a clinical trial sponsor corporation or a Contract Research Organization (CRO). The main responsibilities of a CRA include providing clinical instructions to researchers, ensuring compliance with protocols and regulations, and maintaining a well-balanced clinical trial according to international guidelines, such as the International Conference on Harmonization (ICH) or Good Clinical Practice (GCP).

What do you know about ICH and GCP?

The ICH (International Conference on Harmonization) guidelines for Good Clinical Practice (GCP) establish a harmonized standard to protect human rights and ensure safety and welfare in clinical research. By reducing human exposure to experimental items, enhancing data quality, expediting the commercialization of medications, and lowering costs for sponsors and the public, compliance with ICH-GCP principles ensures that the rights, safety, and well-being of trial participants are respected in accordance with the Declaration of Helsinki's principles. There are 13 main principles of ICH-GCP that can be found on the ICH website for detailed information.

ALSO READ: Interview Questions and Answers for Clinical Pharmacists

What is a placebo in clinical trials?

A placebo refers to an inactive substance or intervention given to participants in a clinical trial under the guise of being an active medicine or treatment. It can be in the form of a tablet, pill, syrup, or any other form. A placebo has no therapeutic effect but is used in processes like blinding, where it is administered instead of the experimental drug to determine the true effects of the treatment being studied.

What is an investigator brochure?

An investigator brochure is a comprehensive document that contains both medical and non-medical data about the experimental product being studied. It provides essential information for the clinical trial and assists in the clinical care and management of the research participants.

What is blinding in a clinical trial?

Blinding in a clinical trial refers to the practice of keeping patients and/or research personnel unaware of who is receiving the experimental medication and who is in the control group (receiving a placebo or standard therapy). Double-blinding occurs when neither the patient nor the researcher knows which group a participant is assigned to, helping minimize bias in the study.

What is a control or control group in a clinical trial?

A control or control group in a clinical trial is a reference group against which the results of the research are measured. In most clinical trials, participants are divided into two groups: the experimental group, which receives the investigational medication or therapy, and the control group, which either receives regular care or a placebo. The control group provides a baseline for comparison to evaluate the effectiveness of the experimental treatment.

What is an Informed Consent Form?

An informed consent form is a document provided to participants in a clinical trial that contains detailed information about the study, including its purpose, duration, required procedures, potential risks and benefits, and key contacts. It is the process through which participants are provided with essential information to help them make an informed decision about whether to participate in the trial or not. Informed consent is not a contract, and participants have the right to withdraw from the trial at any time.

What are Primary and Secondary Endpoints?

In a clinical trial, the primary endpoint refers to the specific event or outcome that the study is designed to assess in order to determine the effect of the drugs or interventions being tested. It addresses the most important question of the trial and is often referred to as the primary outcome measure. On the other hand, secondary endpoints are additional events or outcomes of interest that are not the primary focus of the study but are still measured and analyzed. Secondary endpoints are also known as secondary outcome measures.

What is Treatment Arm?

In a clinical trial, a treatment arm refers to a group of subjects or participants who receive a specific intervention or treatment being tested in the trial. The treatment arm can involve receiving the investigational drug, standard treatment (active comparator arm), placebo (placebo comparator arm), or a sham procedure or device without an active component (sham comparator arm). The purpose of treatment arms is to compare the effects and outcomes of different interventions in the trial.

What is Surrogate Endpoint?

A surrogate endpoint is an indicator or sign used in clinical trials in place of a clinically meaningful outcome to determine if a treatment is effective. Surrogate endpoints, such as a shrinking tumor or lower biomarker levels, may be used as a substitute for stronger measures like longer lifespan or improved quality of life. They are often used in trials for severe or life-threatening diseases, such as cancer, to allow for earlier approval of new drugs. However, it's important to note that surrogate endpoints are not always accurate markers of treatment effectiveness. 

What are the Sources of Trial Ideas?

Clinical trial ideas typically originate from researchers who develop new therapies or procedures. After initial testing in laboratories and animal studies, experimental treatments with promising results are moved into clinical trials. The organization conducting the trial may also make decisions about the therapeutic areas in which they want to develop a new molecule based on various factors such as market size, competition, target country, and the nature of the disease.

What are the Types of Clinical Studies?

There are two main types of clinical studies: observational and interventional.

1. Observational studies: These studies observe participants in their natural settings without any intervention or treatment. They can include various types such as case reports, case series, cross-sectional studies, case-control studies, and cohort studies. Observational studies are valuable for gathering information about the natural history of diseases, identifying risk factors, and generating hypotheses.
2. Interventional studies: These studies involve the administration of an intervention or treatment to participants to evaluate its clinical or pharmacological properties, safety, and efficacy. Interventional studies are designed to answer specific research questions and often follow a structured protocol to assess the effectiveness of a drug, device, or treatment approach.

ALSO READ: SOP for Clinical Trial Monitoring